Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1429Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | REG. NO. BIO120002 | - |
| dc.date.accessioned | 2023-06-24T07:05:35Z | - |
| dc.date.available | 2023-06-24T07:05:35Z | - |
| dc.date.issued | 2023-06-15 | - |
| dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1429 | - |
| dc.description.abstract | Background: Fungal sepsis in neonates is on rise among blood stream infection, it is the third most common etiological agent for sepsis and the changing epidemiology to non-albicans Candida is grossly evident. Fungal isolates are showing azole resistance which were the most common prophylactic treatment used, now made treatment choices difficult for neonate ICU clinicians. Newer class of antifungal drugs especially Echinocandins (Caspofungin) came into real time practice in azole resistant Candida causing sepsis. Objective: 1. To study the prevalence of Candidemia in high-risk neonates of NICU 2. To study Caspofungin (Echinocandin) antifungal susceptibility in Fluconazole resistant Candida isolates by E test / MIC test strip method. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | KLE Academy of Higher Education and Research, Belagavi | en_US |
| dc.subject | Fungal sepsis, Candida, NAC species, critically ill high-risk neonates. | en_US |
| dc.title | prevalence of candidemia in high-risk neonates of neonatal intensive care unit -a one-year cross sectional study. | en_US |
| dc.type | Dissertations | en_US |
| Appears in Collections: | Microbiology | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| BIO120002.pdf | 10.84 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.